Hillsborough, CA, United States of America

Richard L Vandlen

This inventor holds 38 USPTO granted patents and 20 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in IL-22 Fc Fusion Proteins. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 1994-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard L Vandlen. Retrieved from https://idiyas.com/inventor/richard-l-vandlen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 20)

% Patents Active = 68.4

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 13 (Patent Applications = 7)

Average Co-Inventor Count = 4.0

ph-index = 14

Forward Citations = 1,229(Granted Patents)

Location History:

Millsborough, CA (US) (2002)
Hillsborough, CA (US) (1994 - 2022)

Company Filing History:

Years Active: 1994-2022

Loading Chart...

Areas of Expertise:

IL-22 Fc Fusion Proteins

Wound Healing

Cardiovascular Conditions

Metabolic Syndrome

Pharmaceutical Compositions

Multispecific Antibody Panels

Anti-Wall Teichoic Antibodies

Therapeutic Uses

Cysteine Engineered Antibodies

ErbB2 Chimeric Receptors

Interleukin-8 Polypeptides

Heregulin Ligands

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11332507 - IL-22 Fc fusion proteins (2022-05-17),

2. 11155591 - Methods of treating acute pancreatitis using IL-22 fc fusion proteins (2021-10-26),

3. 11136365 - Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins (2021-10-05),

4. 11130791 - Methods for treating metabolic syndrome using IL-22 Fc fusion proteins (2021-09-28),

5. 10584181 - Methods of making and using multispecific antibody panels and antibody analog panels (2020-03-10),

6. 10584155 - Pharmaceutical compositions of IL-22 Fc fusion proteins (2020-03-10),

7. 10570192 - Anti-wall teichoic antibodies and conjugates (2020-02-25),

8. 10544198 - Methods of accelerating or improving wound healing using IL-22 FC fusion proteins (2020-01-28),

9. 10160793 - Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins (2018-12-25),

10. 10087227 - Nucleic acids encoding IL-22 Fc fusion proteins (2018-10-02),

11. 9895450 - Anti-wall teichoic antibodies and conjugates (2018-02-20),

12. 9884126 - Anti-wall teichoic antibodies and conjugates (2018-02-06),

13. 9815880 - IL-22 Fc fusion proteins (2017-11-14),

14. 9803002 - Anti-wall teichoic antibodies and conjugates (2017-10-31),

15. 8338132 - Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof (2012-12-25),

Title: The Innovative Journey of Richard L Vandlen

Introduction:

Richard L Vandlen, a distinguished inventor hailing from Hillsborough, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patented inventions.

Latest Patents:

Richard L Vandlen's latest patents include cutting-edge technologies in the realm of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights:

With a career spanning over two decades, Richard L Vandlen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His patents have revolutionized industries such as healthcare, telecommunications, and sustainable agriculture.

Collaborations:

Throughout his career, Richard L Vandlen has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work across disciplines and industries has led to the successful commercialization of several groundbreaking technologies.

Conclusion:

In conclusion, Richard L Vandlen's passion for innovation, coupled with his relentless drive to make a positive impact on the world, has solidified his reputation as a trailblazing inventor. His continued dedication to pushing the boundaries of technology ensures that his legacy will endure for generations to come.

Profile summary based on public USPTO records.